← All Sponsors
SPONSOR

PharmaMar

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Leiomyosarcoma
NCT06088290 Phase 3
Recruiting

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

Leiomyosarcoma
United States, Austria, Belgium View Trial →